Fatal outcomes of AHASR patients during the study period
| . | Exitus . | Months to death . | |
|---|---|---|---|
| Causes . | Events n/N (%) . | ≤2 mo after Dx§ n/N (%) . | Median (IQR) . |
| All-cause | 36/151 (23.8) | 16/36 (44.4) | 2.7 (1.0-19.0) |
| Infection-related* | 15/36 (41.7) | 7/15 (46.7) | 2.5 (1.5-7.0) |
| Hemorrhage-related† | 5/36 (13.9) | 4/4 (100) | 1.0 (0.4-1.7) |
| Other causes‡ | 16/36 (44.4) | 5/15 (33.3) | 8.0 (1.0-38.0) |
| . | Exitus . | Months to death . | |
|---|---|---|---|
| Causes . | Events n/N (%) . | ≤2 mo after Dx§ n/N (%) . | Median (IQR) . |
| All-cause | 36/151 (23.8) | 16/36 (44.4) | 2.7 (1.0-19.0) |
| Infection-related* | 15/36 (41.7) | 7/15 (46.7) | 2.5 (1.5-7.0) |
| Hemorrhage-related† | 5/36 (13.9) | 4/4 (100) | 1.0 (0.4-1.7) |
| Other causes‡ | 16/36 (44.4) | 5/15 (33.3) | 8.0 (1.0-38.0) |
Missing data were not considered.
Dx, diagnosis.
Sepsis (5, 2 of which caused by pneumonia), pneumonia (4, 1 of which caused by SARS-CoV-2), urinary (1), nonspecified (5).
Pulmonary and cerebral (1), nonspecified (4).
Respiratory failure subsequent to heart failure (3), neoplasia (1), abdominal ischemia (1), fulminant acute hepatitis of unknown origin (1), nonspecified (10).
Calculations were performed considering those patients who died in the first 2 months of follow-up with respect to the whole group of patients who had died by the study end.